膀胱腺癌

目的 提高膀胱腺癌的诊治效果。方法 １２例脐尿管腺癌中，７例行扩大性膀胱部分切除；１５例原发膀胱腺癌中，１１例行膀胱部分切除术。结果 膀胱腺癌总的５年生存率２５．９％．脐尿管腺癌中，７例行扩大性膀胱部分切除者，无一例局部复发，１２例中有４例生存５年。原发膀胱腺癌的治疗主要为膀胱部分切除术，生存５年者３例，局部复发４例，均在原肿瘤部位。

Adenocarcinoma of the urinary bladder: a report of 27 cases]

OBJECTIVE: To analyze the therapeutic results of urinary bladder adenocarcinoma. METHODS: Twenty-seven urinary bladder adenocarcinoma patients were treated from 1970 through 1997. There were 12 cases of urachal adenocarcinoma and 15 cases of bladder adenocarcinoma. Hematuria with or without urinary tract irritation symptoms was the most common clinical manifestation. RESULTS: The overall 5-year survival rate was 25.9%. Among patients with urachal adenocarcinoma, 7 received extended partial bladder resection. None of them had local recurrence. Patients with bladder adenocarcinoma mainly received partial bladder resection, with which 4 developed local recurrence at the primary site. The 5-year survival rate of urachal adenocarcinoma and bladder adenocarcinoma was 33.3% and 20.0%, respectively. One patient of bladder adenocarcinoma with skin and inguinal lymph node metastases and 2 patients of urachal adenocarcinoma with lung metastasis treated with chemotherapy and radiotherapy survived 24, 28 and 60 months, respectively. CONCLUSION: Extended partial bladder resection is the treatment of choice for urachal adenocarcinoma while radical cystectomy for bladder adenocarcinoma. Comprehensive therapy should be given to patients with metastatic or recurrent disease to improve survival.